project id: TCGA-LUAD; case submitter id: TCGA-86-8668; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wgs: false; selected normal wxs: false; state: released; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.38; age at index: 61; days to birth: -22383; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Alive; year of birth: 1951; age at diagnosis: 22383; ajcc pathologic m: M0; ajcc pathologic n: N0; ajcc pathologic stage: Stage IA; ajcc pathologic t: T1b; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 423.0; icd 10 code: C34.3; last known disease status: not reported; morphology: 8253/3; primary diagnosis: Bronchio-alveolar carcinoma, mucinous; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Lower lobe, lung; synchronous malignancy: No; tissue or organ of origin: Lower lobe, lung; tumor grade: Not Reported; year of diagnosis: 2012; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to sample procurement: 0; intermediate dimension: 1.6; longest dimension: 2.0; oct embedded: No; shortest dimension: 0.5; portion submitter id: TCGA-86-8668-01A-11; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent normal cells: 0.0; percent stromal cells: 0.0; percent tumor cells: 100.0;